PubMed

The future of inflammatory bowel disease care.

Sandborn WJ.

Rev Gastroenterol Disord. 2009 Summer;9(3):E69-77.PMID: 19898267 [PubMed - in process]Related articles

The Natural History of Adult Crohn's Disease in Population-Based Cohorts.

Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ.

Am J Gastroenterol. 2009 Oct 27. [Epub ahead of print]PMID: 19861953 [PubMed - as supplied by publisher]Related articles

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg tablet) is Effective for Patients with Moderately Active Ulcerative Colitis.

Sandborn WJ, Regula J, Feagan BG, Belousova E, Jojic N, Lukas M, Yacyshyn B, Krzeski P, Yeh CH, Messer CA, Hanauer SB.

Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766640 [PubMed - as supplied by publisher]Related articles

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.

Baumgart DC, Targan SR, Dignass AU, Mayer L, Assche GV, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ.

Inflamm Bowel Dis. 2009 Aug 27. [Epub ahead of print]PMID: 19714757 [PubMed - as supplied by publisher]Related articles

Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.

Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD.

Aliment Pharmacol Ther. 2009 Nov 1;30(9):930-6. Epub 2009 Aug 12.PMID: 19678812 [PubMed - in process]Related articles

Relationship of C-reactive protein with clinical response after therapy with ustekinumab in Crohn's disease.

Toedter GP, Blank M, Lang Y, Chen D, Sandborn WJ, de Villiers WJ.

Am J Gastroenterol. 2009 Nov;104(11):2768-73. Epub 2009 Aug 11.PMID: 19672253 [PubMed - in process]Related articles

Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride?

Velayos FS, Sandborn WJ.

Am J Gastroenterol. 2009 Aug;104(8):2097-9.PMID: 19661939 [PubMed - indexed for MEDLINE]Related articles

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

D'Haens GR, Fedorak R, Lémann M, Feagan BG, Kamm MA, Cosnes J, Rutgeerts PJ, Marteau P, Travis S, Schölmerich J, Hanauer S, Sandborn WJ; IOIBD Membership.

Inflamm Bowel Dis. 2009 Oct;15(10):1599-604.PMID: 19653291 [PubMed - in process]Related articles

Assessment of appropriateness of indications for CT enterography in younger patients.

Guimarães LS, Fidler JL, Fletcher JG, Bruining DH, Huprich JE, Siddiki H, Sandborn WJ, Loftus EV Jr, Pardi DS, McCollough CH.

Inflamm Bowel Dis. 2009 Jul 27. [Epub ahead of print]PMID: 19637359 [PubMed - as supplied by publisher]Related articles

Disability in inflammatory bowel diseases: Developing ICF core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health.

Peyrin-Biroulet L, Cieza A, Sandborn WJ, Kostanjsek N, Kamm MA, Hibi T, Lémann M, Stucki G, Colombel JF.

Inflamm Bowel Dis. 2009 Jul 16. [Epub ahead of print]PMID: 19610077 [PubMed - as supplied by publisher]Related articles

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.

Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

Gastroenterology. 2009 Oct;137(4):1250-60; quiz 1520. Epub 2009 Jul 28.PMID: 19596014 [PubMed - indexed for MEDLINE]Related articles

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease.

Siddiki HA, Fidler JL, Fletcher JG, Burton SS, Huprich JE, Hough DM, Johnson CD, Bruining DH, Loftus EV Jr, Sandborn WJ, Pardi DS, Mandrekar JN.

AJR Am J Roentgenol. 2009 Jul;193(1):113-21.PMID: 19542402 [PubMed - indexed for MEDLINE]Related articles

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

Marehbian J, Arrighi HM, Hass S, Tian H, Sandborn WJ.

Am J Gastroenterol. 2009 Oct;104(10):2524-33. Epub 2009 Jun 16.PMID: 19532125 [PubMed - indexed for MEDLINE]Related articles

Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.

Peyrin-Biroulet L, Colombel JF, Sandborn WJ.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1139. Epub 2009 May 22. No abstract available. PMID: 19465159 [PubMed - in process]Related articles

Adalimumab safety in global clinical trials of patients with Crohn's disease.

Colombel JF, Sandborn WJ, Panaccione R, Robinson AM, Lau W, Li J, Cardoso AT.

Inflamm Bowel Dis. 2009 Sep;15(9):1308-19.PMID: 19434735 [PubMed - indexed for MEDLINE]Related articles

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.

Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ.

Inflamm Bowel Dis. 2009 Sep;15(9):1302-7.PMID: 19408340 [PubMed - indexed for MEDLINE]Related articles

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.

Lichtenstein GR, Diamond RH, Wagner CL, Fasanmade AA, Olson AD, Marano CW, Johanns J, Lang Y, Sandborn WJ.

Aliment Pharmacol Ther. 2009 Aug;30(3):210-26. Epub 2009 Apr 21.PMID: 19392858 [PubMed - in process]Related articles

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.

Colombel JF, Sandborn WJ, Rutgeerts P, Kamm MA, Yu AP, Wu EQ, Pollack PF, Lomax KG, Chao J, Mulani PM.

Am J Gastroenterol. 2009 May;104(5):1170-9. Epub 2009 Apr 7.PMID: 19352339 [PubMed - indexed for MEDLINE]Related articles

MHC Class II alleles in ulcerative colitis-associated colorectal cancer.

Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC.

Gut. 2009 Sep;58(9):1226-33. Epub 2009 Feb 26.PMID: 19251712 [PubMed - indexed for MEDLINE]Related articles

Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease.

Baumgart DC, Lowder JN, Targan SR, Sandborn WJ, Frankel MB.

Am J Gastroenterol. 2009 Apr;104(4):868-76. Epub 2009 Feb 24.PMID: 19240707 [PubMed - indexed for MEDLINE]Related articles

Inflammatory bowel disease in the setting of autoimmune pancreatitis.

Ravi K, Chari ST, Vege SS, Sandborn WJ, Smyrk TC, Loftus EV Jr.

Inflamm Bowel Dis. 2009 Sep;15(9):1326-30.PMID: 19235915 [PubMed - indexed for MEDLINE]Related articles

Adalimumab for the treatment of fistulas in patients with Crohn's disease.

Colombel JF, Schwartz DA, Sandborn WJ, Kamm MA, D'Haens G, Rutgeerts P, Enns R, Panaccione R, Schreiber S, Li J, Kent JD, Lomax KG, Pollack PF.

Gut. 2009 Jul;58(7):940-8. Epub 2009 Feb 6.PMID: 19201775 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of Crohn's disease in adults.

Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology.

Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484. Epub 2009 Jan 6.PMID: 19174807 [PubMed - indexed for MEDLINE]Related articles

Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States.

Loftus EV Jr, Friedman HS, Delgado DJ, Sandborn WJ.

Inflamm Bowel Dis. 2009 Apr;15(4):566-75.PMID: 19143006 [PubMed - indexed for MEDLINE]Related articles

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.

Abreu MT, von Tirpitz C, Hardi R, Kaatz M, Van Assche G, Rutgeerts P, Bisaccia E, Goerdt S, Hanauer S, Knobler R, Mannon P, Mayer L, Ochsenkuhn T, Sandborn WJ, Parenti D, Lee K, Reinisch W; Crohn's Disease Photopheresis Study Group.

Inflamm Bowel Dis. 2009 Jun;15(6):829-36.PMID: 19130617 [PubMed - indexed for MEDLINE]Related articles

Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study.

Hanson KA, Loftus EV Jr, Harmsen WS, Diehl NN, Zinsmeister AR, Sandborn WJ.

Inflamm Bowel Dis. 2009 May;15(5):772-7.PMID: 19107782 [PubMed - indexed for MEDLINE]Related articles

Mucosal healing in inflammatory bowel disease.

Sandborn WJ.

Rev Gastroenterol Disord. 2008 Fall;8(4):271-2. No abstract available. PMID: 19107101 [PubMed]Related articles

An update on the epidemiology of inflammatory bowel disease in Asia.

Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK.

Am J Gastroenterol. 2008 Dec;103(12):3167-82. Review.PMID: 19086963 [PubMed - indexed for MEDLINE]Related articles

Relationships between C-reactive protein concentration and genotype in healthy volunteers.

Jones J, Chen LS, Baudhuin L, Peterson S, Harmsen WS, Zinsmeister AR, McConnell J, Sandborn WJ.

Clin Chem Lab Med. 2009;47(1):20-5.PMID: 19072030 [PubMed - indexed for MEDLINE]Related articles

AGA Institute Future Trends Committee report: the future of gastroenterology training programs in the United States.

Wang TC, Cominelli F, Fleischer DE, Gordon JM, Glickman RM, Limsui D, McQuaid KR, Montrose M, Pasricha PJ, Powell DW, Rowe WA, Sandborn WJ, Todisco A.

Gastroenterology. 2008 Nov;135(5):1764-89.e2. No abstract available. PMID: 19009690 [PubMed - indexed for MEDLINE]Related articles

Current directions in IBD therapy: what goals are feasible with biological modifiers?

Sandborn WJ.

Gastroenterology. 2008 Nov;135(5):1442-7. Epub 2008 Oct 9. Review. No abstract available. PMID: 18848556 [PubMed - indexed for MEDLINE]Related articles

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.

Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV Jr, Lomax KG, Yu AP, Wu EQ, Chao J, Mulani P.

Gastroenterology. 2008 Nov;135(5):1493-9. Epub 2008 Aug 3.PMID: 18848553 [PubMed - indexed for MEDLINE]Related articles

Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.

Sandborn WJ.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S232-3. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47. PMID: 18816658 [PubMed - in process]Related articlesFree article

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

Jones J, Loftus EV Jr, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24. Epub 2008 Sep 17.PMID: 18799360 [PubMed - indexed for MEDLINE]Related articles

Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.

Thia KT, Sandborn WJ, Lewis JD, Loftus EV Jr, Feagan BG, Steinhart AH, Hanauer SB, Persson T, Sands BE.

Am J Gastroenterol. 2008 Dec;103(12):3123-31.PMID: 18786111 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group.

Gastroenterology. 2008 Oct;135(4):1130-41. Epub 2008 Jul 17.PMID: 18706417 [PubMed - indexed for MEDLINE]Related articles

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.

Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R.

Inflamm Bowel Dis. 2009 Jan;15(1):1-8.PMID: 18671232 [PubMed - indexed for MEDLINE]Related articles

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.

Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ.

Inflamm Bowel Dis. 2009 Jan;15(1):17-24.PMID: 18668682 [PubMed - indexed for MEDLINE]Related articles

Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography.

Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr.

Inflamm Bowel Dis. 2008 Dec;14(12):1701-6.PMID: 18623171 [PubMed - indexed for MEDLINE]Related articles

Crohn's disease: beyond antagonists of tumour necrosis factor.

Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF.

Lancet. 2008 Jul 5;372(9632):67-81. Review.PMID: 18603161 [PubMed - indexed for MEDLINE]Related articles

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.

Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S; Adacolumn Study Group.

Gastroenterology. 2008 Aug;135(2):400-9. Epub 2008 Apr 25.PMID: 18602921 [PubMed - indexed for MEDLINE]Related articles

Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States.

Loftus EV Jr, Delgado DJ, Friedman HS, Sandborn WJ.

Am J Gastroenterol. 2008 Jul;103(7):1737-45. Epub 2008 Jun 28.PMID: 18564126 [PubMed - indexed for MEDLINE]Related articles

Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease.

Peloquin JM, Pardi DS, Sandborn WJ, Fletcher JG, McCollough CH, Schueler BA, Kofler JA, Enders FT, Achenbach SJ, Loftus EV Jr.

Am J Gastroenterol. 2008 Aug;103(8):2015-22. Epub 2008 Jun 28.PMID: 18564113 [PubMed - indexed for MEDLINE]Related articles

CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findings.

Booya F, Akram S, Fletcher JG, Huprich JE, Johnson CD, Fidler JL, Barlow JM, Solem CA, Sandborn WJ, Loftus EV Jr.

Abdom Imaging. 2009 Jul;34(4):467-75.PMID: 18551336 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF.

Clin Gastroenterol Hepatol. 2008 Jun;6(6):644-53.PMID: 18550004 [PubMed - indexed for MEDLINE]Related articles

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.

Panaccione R, Rutgeerts P, Sandborn WJ, Feagan B, Schreiber S, Ghosh S.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):674-88. Review.PMID: 18532990 [PubMed - indexed for MEDLINE]Related articles

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, Tremaine WJ, Egan LJ, Faubion WA, Schroeder KW, Pardi DS, Hanson KA, Jewell DA, Barlow JM, Fidler JL, Huprich JE, Johnson CD, Harmsen WS, Zinsmeister AR, Sandborn WJ.

Gastrointest Endosc. 2008 Aug;68(2):255-66. Epub 2008 Jun 2.PMID: 18513722 [PubMed - indexed for MEDLINE]Related articles

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.

Feagan BG, Sandborn WJ, Mittmann U, Bar-Meir S, D'Haens G, Bradette M, Cohen A, Dallaire C, Ponich TP, McDonald JW, Hébuterne X, Paré P, Klvana P, Niv Y, Ardizzone S, Alexeeva O, Rostom A, Kiudelis G, Spleiss J, Gilgen D, Vandervoort MK, Wong CJ, Zou GY, Donner A, Rutgeerts P.

JAMA. 2008 Apr 9;299(14):1690-7.PMID: 18398081 [PubMed - indexed for MEDLINE]Related articlesFree article

Positioning biologic therapy for Crohn's disease and ulcerative colitis.

Velayos FS, Sandborn WJ.

Curr Gastroenterol Rep. 2007 Dec;9(6):521-7. Review.PMID: 18377806 [PubMed - indexed for MEDLINE]Related articles

MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.

Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE.

Aliment Pharmacol Ther. 2008 Jun 1;27(11):1094-102. Epub 2008 Mar 22.PMID: 18363894 [PubMed - indexed for MEDLINE]Related articles